Skip to Content

Mozobil Prices, Coupons and Patient Assistance Programs

Mozobil (plerixafor) is a member of the hematopoietic stem cell mobilizer drug class and is commonly used for Multiple Myeloma and Non-Hodgkin's Lymphoma.

Mozobil Prices

This Mozobil price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Mozobil subcutaneous solution (20 mg/mL) is around $7,593 for a supply of 1.2 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Mozobil is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Mozobil availability.

Subcutaneous Solution

20 mg/mL Mozobil subcutaneous solution
from $7,592.85 for 1.2 milliliters
Quantity Per unit Price
1.2 milliliters $6,327.38 $7,592.85

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Mozobil Coupons and Rebates

Mozobil offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Patient Assistance Programs for Mozobil

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Sanofi Patient Connection Program

Elligibility requirements:

  1. Must have no prescription insurance, be ineligible for any state and federal programs
  2. At or below 500% of FPL for oncology products and at or below 250% of FPL for all other products
  3. Medically appropriate condition/diagnosis
  4. The patient must also be a US resident.
  5. Negative decision may be appealed. Insurance benefits, claims assistance and/or other reimbursement help is offered. Exceptions to guidelines considered. Patients who do not file taxes must either request a 4506-T form from the IRS, submit proof of benefits received (such as Social Security) Earning Statement, or submit W2's of the person who is supporting them financially. Healthcare provider must contact the Program for REORDER FORMS. *On most medications, excluding Lovenox, patients with Medicare Part D may be considered if they are not eligible for Low Income Subsidy, and they have spent at least 5% of annual household income on out-of-pocket costs for medications.

Applicable drugs:

  • Mozobil (plerixafor) Injection

Provider: HealthWell Foundation Copay Program

Elligibility requirements:

  1. May have insurance
  2. Varies
  3. Medically appropriate condition/diagnosis
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Mozobil (plerixafor)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Mozobil (plerixafor)
Hide